Cardiovascular consequences of early-onset growth hormone excess

Journal of Clinical Endocrinology and Metabolism

Volumn 87, Issue 7, 2002, Pages 3097-3104

  Colao, Annamaria ^a,d   Spinelli, Letizia ^a   Cuocolo, Alberto ^b   Spiezia, Stefano ^c   Pivonello, Rosario ^b   Somma, Carolina Di ^a   Bonaduce, Domenico ^a   Salvatore, Marco ^a   Lombardi, Gaetano ^a  

^a Department of Molecular and Clinical Endocrinology and Oncology ^*  (Italy)

^b Internal Medicine I

^c Department of Biomorphological and Functional Sciences   (Italy)

^d UNIVERSITY OF NAPLES FEDERICO II   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

GROWTH HORMONE; SOMATOMEDIN C;

ACROMEGALY; ADULT; ARTICLE; ATHEROSCLEROTIC PLAQUE; CARDIOMYOPATHY; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CLINICAL ARTICLE; COMMON CAROTID ARTERY; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; DISEASE ASSOCIATION; DOPPLER ECHOCARDIOGRAPHY; DOPPLER FLOWMETRY; EXERCISE; FEMALE; HEART EJECTION FRACTION; HEART FUNCTION; HEART LEFT VENTRICLE HYPERTROPHY; HEART PERFORMANCE; HEART RATE; HUMAN; M MODE ECHOCARDIOGRAPHY; MALE; MORPHOLOGY; ONSET AGE; PRIORITY JOURNAL; SCINTIANGIOGRAPHY; SYSTOLIC BLOOD PRESSURE; VASCULAR DISEASE;

EID: 0036318922     PISSN: 0021972X     EISSN: None     Source Type: Journal    
DOI: 10.1210/jcem.87.7.8573     Document Type: Article

References (43)

1. Growth hormone and the heart
2. Acromegaly and the heart: A clinical and pathologic study
3. Pathology of the heart in acromegaly: Anatomic findings in 27 autopsied patients
4. Cardiac involvement in acromegaly: Specific myocardiopathy or consequence of systemic hypertension
5. Systemic hypertension and im-paired glucose tolerance are independently correlated to the severity of the acromegalic cardiomyopathy
6. Cardiac effect of thyrotoxicosis in acromegaly
7. Acromegaly
8. Echocardiographic evidence for a direct effect of GH/IGF-I hypersecretion on cardiac mass and function in young acromegalics
9. Cardiovascular effects of short-term growth hormone hypersecretion
10. Increased arterial intima-media thickness by B-M mode echodoppler ultrasonography in acromegaly
11. Characterization of premature atherosclerosis of carotid arteries in acromegalic patients
12. A preliminary study of growth hormone in the treatment of dilated cardiomyopathy
13. Hemodynamic effects of intravenous growth hormone in congestive heart failure
14. A placebo-controlled study of growth hormone in patients with congestive heart failure
15. Randomised, double-blind placebo-controlled trial of human recombinant growth hormone in patients with chronic heart failure due to dilated cardiomyopathy
16. Effects of excessive secretion of growth hormone on tissue of the rat, with particular reference to the heart and skeletal muscle
17. Effects of chronic growth hormone hypersecretion on intrinsic contractility, energetics, isomyosin pattern, and myosine adenosine triphosphatase activity of rat left ventricle
18. Mechanical properties of rat cardiac skinned fibers are altered by chronic growth hormone hypersecretion
19. Differential cardiac effects of growth hormone and IGF-I in the rat: A combined in vivo and in vitro evaluation
20. Exogenously administered growth hormone and IGF-I alter intracellular calcium handling and enhance cardiac performance: In vitro evaluation in the isolated isovolumic buffer perfused rat heart
21. Increased myocardial contractility following growth hormone administration in normal men
22. Growth hormone and prolactin excess
23. Hypertension control. Report of a WHO expert committee
24. WHO expert committee on diabetes mellitus: Second report
25. Treatment of hypertriglyceridemia
26. Expert Panel Report of the National Cholesterol Education Program Expert Panel on detection, evaluation and treatment of high blood cholesterol in adults
27. Prediction of efficacy of octreotide therapy in patients with acromegaly
28. Cardiovascular effects of depot long-acting somatostatin analog Sandostatin LAR® in acromegaly
29. Long-term effects of depot long-acting somatostatin analog octreotide on hormone levels and tumor mass in acromegaly
30. Criteria for cure of acromegaly: A consensus statement
31. The committee on M-mode standardization of the American Society of Echocardiography. Recommendations regarding quantification in M-mode echocardiography: Results of a survey of echocardiography measurements
32. Detection of left ventricular hypertrophy by M-mode echocardiography. Anatomic validation, standardization, and comparison to other methods
33. Estimation of arterial stiffness, compliance and distensibility from M-mode ultrasound measurements of the common carotid artery
34. Growth hormone and the heart
35. Water and sodium in patients with acromegaly
36. Expansion of extracellular volume and suppression of atrial natriuretic peptide after growth hormone administration in normal man
37. Results of a European multicentre study with sandostatin LAR in acromegalic patients
38. Pharmacotherapy or surgery as primary treatment for acromegaly?
39. Short term reduction of left ventricular mass in primary hypertrophic cardiomyopathy by octreotide injections
40. Effects of octreotide in patients with hypertrophic obstructive cardiomyopathy
41. Localisation and quantitation of autonomic innervation in the porcine heart. I. Conduction system
42. Is the acromegalic cardiomyopathy reversible? Effect of 5-year normalization of growth hormone and insulin-like growth factor I levels on cardiac performance
43. Reversal of acromegalic cardiomyopathy in young but not in middle-aged patients after 12 months of treatment with the depot long-acting somatostatin analogue octreotide